Octahydroisoquinoline compounds as opioid receptor modulators

Compounds which bind to opioid receptors are provided. In a preferred embodiment of the invention, the compounds are opioid receptor antagonists. The present invention also provides methods of treating conditions which are mediated by an opioid receptor.

Carroll, F., Navarro, H., Mascarella, S., & Thomas, J. (2009). IPC No. U.S. Octahydroisoquinoline compounds as opioid receptor modulators. (Patent No. 7476679).